Ongoing Monoclonal Antibodies and Plasmids Services through GENSCRIPT

PRE-SOLICITATION NOTICE **NOTICE OF INTENT TO SOLE SOURCE

NOI-NIAID-25-2253129

NAICS – 541380, Testing Services

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with GenScript USA Inc of Piscataway, NJ to procure ongoing monoclonal antibodies and plasmids services for the NIAID Laboratory of Immunogenetics (LIG).

The National Institute of Allergy and Infectious Diseases (NIAID) Antibody Biology Unit (ABU) of the Laboratory of Immunogenetics (LIG), in furtherance of its mission to advance knowledge of human B cells and isolation of monoclonal antibodies, requires a service that provides custom Gene to Antibodies, plasmid heavy chain, and plasmid light chain preparation. These custom antibody and plasmid services can be used to design new vaccine candidates against influenza. The Antibody Biology Unit (ABU) has using GenScript for custom gene to antibody, plasmid heavy chain, and plasmid light chain services, and this is continuation of a master project that requires some additional work. Continuity is required to retain comparison of results.

The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement. All required documents must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov by January 3, 2025 at 5:00 pm ET. All vendors must register in the eSASS system to submit their documentation. Instructions on how to register /submit documents are included on the website. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.